| 产品名称： | J27-B7 |
|---|---|
| 商品货号： | TS211739 |
| Organism： | Mus musculus, mouse |
| Product Format： | frozen |
| Morphology： | fibroblast |
| Culture Properties： | adherent |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Strain： | C3H |
| Applications： | J27-B7 is a stable transfected cell line established in 1987 by transfection with calcium phosphate of the J27.2 cell line with a modified neomycin drug-resistant eukaryotic vector, pSP65 containing a genomic human B7 gene (gB7). J27-B7 expresses surface HLA B7 but does not secrete HLA B7. |
| Derivation： | J27-B7 is a stable transfected cell line established in 1987 by transfection with calcium phosphate of the J27.2 cell line with a modified neomycin drug-resistant eukaryotic vector, pSP65 containing a genomic human B7 gene (gB7). |
| Antigen Expression： | HLA B7 |
| Genes Expressed： | HLA B7 |
| Comments： | J27-B7 is a stable transfected cell line established in 1987 by transfection with calcium phosphate of the J27.2 cell line with a modified neomycin drug-resistant eukaryotic vector, pSP65 containing a genomic human B7 gene (gB7). The cells were selected in HAT and G418. J27-B7 expresses surface HLA B7 but does not secrete HLA B7. |
| Complete Growth Medium： | The base medium for this cell line is ATCC-formulated Iscoves Modified Dulbeccos Medium, Catalog No. 30-2005. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
|
| Subculturing： | Subcultivation Ratio: A subcultivation ratio of 1:4 to 1:6 is recommended Medium Renewal: Every 2 to 3 days Remove medium, and rinse with 0.25% trypsin, 0.03% EDTA solution. Remove the solution and add an additional 1 to 2 ml of trypsin-EDTA solution. Allow the flask to sit at room temperature (or at 37C) until the cells detach. Add fresh culture medium, aspirate and dispense into new culture flasks. |
| Cryopreservation： | culture medium 95%; DMSO, 5% |
| Culture Conditions： | Temperature: 37.0°C |
| Name of Depositor： | F Grumet |
| Year of Origin： | 1987 |
| References： | Kavathas P, Herzenberg LA. Stable transformation of mouse L cells for human membrane T-cell differentiation antigens, HLA and beta 2-microglobulin: selection by fluorescence-activated cell sorting. Proc. Natl. Acad. Sci. USA 80: 524-528, 1983. PubMed: 6188154 Hiraki DD, et al. Bioengineered soluble HLA-B7. Genesis, characterization, and occurrence of dimerization. Hum. Immunol. 40: 235-246, 1994. PubMed: 7960968 Cohen N, et al. Secretion of genetically engineered human/mouse class I antigens. Hum. Immunol. 25: 207-222, 1989. PubMed: 2670852 |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | J27-B7 |
|---|---|
| 商品货号： | TS211739 |
| Organism： | Mus musculus, mouse |
| Product Format： | frozen |
| Morphology： | fibroblast |
| Culture Properties： | adherent |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Strain： | C3H |
| Applications： | J27-B7 is a stable transfected cell line established in 1987 by transfection with calcium phosphate of the J27.2 cell line with a modified neomycin drug-resistant eukaryotic vector, pSP65 containing a genomic human B7 gene (gB7). J27-B7 expresses surface HLA B7 but does not secrete HLA B7. |
| Derivation： | J27-B7 is a stable transfected cell line established in 1987 by transfection with calcium phosphate of the J27.2 cell line with a modified neomycin drug-resistant eukaryotic vector, pSP65 containing a genomic human B7 gene (gB7). |
| Antigen Expression： | HLA B7 |
| Genes Expressed： | HLA B7 |
| Comments： | J27-B7 is a stable transfected cell line established in 1987 by transfection with calcium phosphate of the J27.2 cell line with a modified neomycin drug-resistant eukaryotic vector, pSP65 containing a genomic human B7 gene (gB7). The cells were selected in HAT and G418. J27-B7 expresses surface HLA B7 but does not secrete HLA B7. |
| Complete Growth Medium： | The base medium for this cell line is ATCC-formulated Iscoves Modified Dulbeccos Medium, Catalog No. 30-2005. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
|
| Subculturing： | Subcultivation Ratio: A subcultivation ratio of 1:4 to 1:6 is recommended Medium Renewal: Every 2 to 3 days Remove medium, and rinse with 0.25% trypsin, 0.03% EDTA solution. Remove the solution and add an additional 1 to 2 ml of trypsin-EDTA solution. Allow the flask to sit at room temperature (or at 37C) until the cells detach. Add fresh culture medium, aspirate and dispense into new culture flasks. |
| Cryopreservation： | culture medium 95%; DMSO, 5% |
| Culture Conditions： | Temperature: 37.0°C |
| Name of Depositor： | F Grumet |
| Year of Origin： | 1987 |
| References： | Kavathas P, Herzenberg LA. Stable transformation of mouse L cells for human membrane T-cell differentiation antigens, HLA and beta 2-microglobulin: selection by fluorescence-activated cell sorting. Proc. Natl. Acad. Sci. USA 80: 524-528, 1983. PubMed: 6188154 Hiraki DD, et al. Bioengineered soluble HLA-B7. Genesis, characterization, and occurrence of dimerization. Hum. Immunol. 40: 235-246, 1994. PubMed: 7960968 Cohen N, et al. Secretion of genetically engineered human/mouse class I antigens. Hum. Immunol. 25: 207-222, 1989. PubMed: 2670852 |
